Literature DB >> 21812941

Explained variance for blood gases in a population with COPD.

Eirunn Waatevik Saure1, Tomas Mikal Lind Eagan, Robert Leroy Jensen, Marianne Voll-Aanerud, Pål Aukrust, Per Sigvald Bakke, Jon Andrew Hardie.   

Abstract

INTRODUCTION: Variation of blood gas levels in chronic obstructive pulmonary disease (COPD) patients has not been extensively reported and there is limited knowledge about predictors of chronic respiratory failure in COPD patients.
OBJECTIVES: The aim of this study was to identify predictors of hypoxemia, hypercapnia and increased alveolar-arterial oxygen difference in COPD patients. We hypothesized that prediction of arterial blood gases will be improved in multivariate models including measurements of lung function, anthropometry and systemic inflammation.
METHODS: A cross-sectional sample of 382 Norwegian COPD patients, age 40-76, Global Initiative for Chronic Obstructive Lung Disease stage II-IV, with a smoking history of at least 10 pack-years, underwent extensive measurements, including medical examination, arterial blood gases, systemic inflammatory markers, spirometry, plethysmography, respiratory impedance and bioelectrical impedance. Possible predictors of arterial oxygen (PaO(2)), arterial carbon dioxide (PaCO(2)) and alveolar-arterial oxygen difference (AaO(2)) were analyzed with both bivariate and multiple regression methods.
RESULTS: We found that various lung function measurements were significantly associated with PaO2, PaCO(2) and AaO(2). In addition, heart rate and Fat Mass Index were predictors of PaO(2) and AaO(2), while heart failure and current smoking status were associated with PaCO(2). The explained variance (R(2)) in the final multivariate regression models was 0.14-0.20.
CONCLUSIONS: With a wide assortment of possible clinical predictors, we could explain 14-20% of the variation in blood gas measurements in COPD patients.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21812941     DOI: 10.1111/j.1752-699X.2011.00248.x

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  11 in total

Review 1.  Chronic hypoventilation syndromes and sleep-related hypoventilation.

Authors:  Sebastian Böing; Winfried J Randerath
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

2.  Chronic obstructive pulmonary disease is associated with low levels of vitamin D.

Authors:  Louise Jeanette Pauline Persson; Marianne Aanerud; Pieter Sicco Hiemstra; Jon Andrew Hardie; Per Sigvald Bakke; Tomas Mikal Lind Eagan
Journal:  PLoS One       Date:  2012-06-21       Impact factor: 3.240

3.  Functional capacity, physical activity, and quality of life in hypoxemic patients with chronic obstructive pulmonary disease.

Authors:  Melda Saglam; Naciye Vardar-Yagli; Sema Savci; Deniz Inal-Ince; Ebru Calik-Kutukcu; Hülya Arikan; Lutfi Coplu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-02-26

4.  Sleep hypoventilation and daytime hypercapnia in stable chronic obstructive pulmonary disease.

Authors:  Nils Henrik Holmedahl; Britt Øverland; Ove Fondenes; Ivar Ellingsen; Jon Andrew Hardie
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-02-27

5.  Predictors of exacerbations in chronic obstructive pulmonary disease--results from the Bergen COPD cohort study.

Authors:  Gunnar R Husebø; Per S Bakke; Marianne Aanerud; Jon A Hardie; Thor Ueland; Rune Grønseth; Louise J P Persson; Pål Aukrust; Tomas M Eagan
Journal:  PLoS One       Date:  2014-10-03       Impact factor: 3.240

6.  Short-Term Intra-Subject Variation in Exhaled Volatile Organic Compounds (VOCs) in COPD Patients and Healthy Controls and Its Effect on Disease Classification.

Authors:  Christopher Phillips; Neil Mac Parthaláin; Yasir Syed; Davide Deganello; Timothy Claypole; Keir Lewis
Journal:  Metabolites       Date:  2014-05-09

7.  Diffusion capacity and CT measures of emphysema and airway wall thickness - relation to arterial oxygen tension in COPD patients.

Authors:  Eirunn Waatevik Saure; Per Sigvald Bakke; Tomas Mikal Lind Eagan; Marianne Aanerud; Robert Leroy Jensen; Thomas Blix Grydeland; Ane Johannessen; Roy Miodini Nilsen; Einar Thorsen; Jon Andrew Hardie
Journal:  Eur Clin Respir J       Date:  2016-05-12

8.  Evaluation of oxygen prescription in relation to hospital admission rate in patients with chronic obstructive pulmonary disease.

Authors:  Alice M Turner; Sourav Sen; Cathryn Steeley; Yasmin Khan; Pamela Sweeney; Yvonne Richards; Rahul Mukherjee
Journal:  BMC Pulm Med       Date:  2014-08-05       Impact factor: 3.317

Review 9.  Cachexia in chronic obstructive pulmonary disease: new insights and therapeutic perspective.

Authors:  Karin J C Sanders; Anita E M Kneppers; Coby van de Bool; Ramon C J Langen; Annemie M W J Schols
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-09-07       Impact factor: 12.910

10.  Development and Relevance of Hypercapnia in COPD.

Authors:  Chirag Dave; Simon Wharton; Rahul Mukherjee; Bandar M Faqihi; Robert A Stockley; Alice M Turner
Journal:  Can Respir J       Date:  2021-02-22       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.